Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$4.73B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$739M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$255M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$201M |
Top Sells
| 1 |
Apple
AAPL
|
+$782M |
| 2 |
Microsoft
MSFT
|
+$705M |
| 3 |
iShares MBS ETF
MBB
|
+$605M |
| 4 |
Linde
LIN
|
+$454M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$418M |
Sector Composition
| 1 | Technology | 17.22% |
| 2 | Healthcare | 10.49% |
| 3 | Financials | 9.69% |
| 4 | Communication Services | 7.9% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Achieve Life Sciences
ACHV
$163M
| $37K | ﹤0.01% |
5,671
+5,670
| +567,000% | +$37K |
|
3127
Ascendis Pharma
ASND
$11.9B
| $37K | ﹤0.01% |
329
-49
| -13% | -$5.51K |
|
3128
GSI Technology
GSIT
$95.4M
| $37K | ﹤0.01% |
5,285
-10,894
| -67% | -$76.3K |
|
|
OTRK
3129
DELISTED
Ontrak
OTRK
| $37K | ﹤0.01% |
26
-54
| -68% | -$76.8K |
|
|
RPT
3130
Rithm Property Trust Inc.
RPT
$124M
| $37K | ﹤0.01% |
5,803
-12,372
| -68% | -$78.9K |
|
|
ENZ
3131
DELISTED
Enzo Biochem, Inc.
ENZ
| $37K | ﹤0.01% |
14,608
-30,371
| -68% | -$76.9K |
|
|
TMBR
3132
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $37K | ﹤0.01% |
203
| – | – |
|
|
MFNC
3133
DELISTED
Mackinac Financial Corporation
MFNC
| $37K | ﹤0.01% |
3,657
-5,736
| -61% | -$58K |
|
3134
Arcturus Therapeutics
ARCT
$490M
| $36K | ﹤0.01% |
2,674
+2,324
| +664% | +$31.3K |
|
3135
KB Financial Group
KB
$30.6B
| $36K | ﹤0.01% |
1,311
| – | – |
|
3136
Astrana Health
ASTH
$1.39B
| $36K | ﹤0.01% |
2,706
-3,543
| -57% | -$47.1K |
|
|
HURA
3137
TuHURA Biosciences, Inc. Common Stock
HURA
$129M
| $36K | ﹤0.01% |
51
| – | – |
|
|
SFE
3138
DELISTED
Safeguard Scientifics, Inc.
SFE
| $36K | ﹤0.01% |
6,573
-13,015
| -66% | -$71.3K |
|
|
ACOR
3139
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $36K | ﹤0.01% |
322
-262
| -45% | -$29.3K |
|
3140
Acacia Research
ACTG
$312M
| $35K | ﹤0.01% |
15,644
-34,518
| -69% | -$77.2K |
|
3141
DHI Group
DHX
$142M
| $35K | ﹤0.01% |
16,656
-34,450
| -67% | -$72.4K |
|
3142
Duluth Holdings
DLTH
$136M
| $35K | ﹤0.01% |
8,817
-3,469
| -28% | -$13.8K |
|
3143
Eastern Company
EML
$152M
| $35K | ﹤0.01% |
1,780
-3,734
| -68% | -$73.4K |
|
3144
Information Services Group
III
$249M
| $35K | ﹤0.01% |
13,582
-24,578
| -64% | -$63.3K |
|
3145
SemiLEDS
LEDS
$16.1M
| $35K | ﹤0.01% |
18,353
-4,200
| -19% | -$8.01K |
|
3146
Riverview Bancorp
RVSB
$104M
| $35K | ﹤0.01% |
7,036
-14,631
| -68% | -$72.8K |
|
3147
Arq
ARQ
$301M
| $35K | ﹤0.01% |
5,456
-61,772
| -92% | -$396K |
|
|
TCS
3148
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $35K | ﹤0.01% |
981
-100
| -9% | -$3.57K |
|
|
PHAS
3149
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $35K | ﹤0.01% |
10,635
-11,334
| -52% | -$37.3K |
|
|
GCAP
3150
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $35K | ﹤0.01% |
6,398
-13,299
| -68% | -$72.8K |
|